Advanced search
Publication Cover
Journal of Medical Economics Volume 3, 2000 - Issue 1-4
Submit an article Journal homepage
74
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Economic evaluation of ramipril in the treatment of patients at high risk for cardiovascular events

Martin E. Backhouse Research Triangle Institute, Director of European Operations,Center for Economics Research, Manchester, UKCorrespondence[email protected]
,
Anke Richter Research Triangle Institute, Senior Research Management Scientist,Center for Economics Research, Manchester, UK
&
Louise Gaffney Research Triangle Institute, Economist,Center for Economics Research, Manchester, UK
Pages 97-109 | Accepted 29 Nov 2000, Published online: 17 Dec 2008

References

  • British Heart Foundation Health Promotion Research Group (1999) Coronary heart disease statistics.The British Heart Foundation, London: 3-100.
  • The Heart Outcomes Prevention Evaluation Study Investigators (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. New England Journal of Medicine 342: 145–153.
  • Towse AE (1997) Guidelines for the economic evaluation of pharmaceuticals. Office of Health Economics, London.
  • Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW (1997) Methods for the economic evaluation of health care programmes. Oxford University Press, Oxford.
  • Briggs A, Sculpher M, Buxton M (1994) Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Economics 3: 95–104.
  • Briggs A, Gray A (1999) Handling uncertainty in economic evaluations of healthcare interventions. British Medical Journal 319: 635–638.
  • NHS Management Executive (1999) The new NHS reference costs. Department of Health, Leeds.
  • Beck RJ, Kassirer JP, Pauker SG (1982a) A convenient approximation of life expectancy: I validation of the method. American Journal of Medicine 73: 883–888.
  • Beck RJ, Pauker SG, Gottlieb JE, Klein K, Kassirer JP (1982b) A convenient approximation of life expectancy: II Use in medical decision-making. The American Journal of Medicine 73: 889–897.
  • NICE Appraisal Committee (2000) Guidance on the use of taxanes for breast cancer. http://www.nice.org.uk/.
  • Government Actuary Interim Life Tables (2000) Expectation of life, United Kingdom, males and females.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.